Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania-Reference-Cited by-同舟云学术

Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania

Published:2012-07-11 Issue:7 Volume:7 Page:e40180
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mugusi Sabina,Ngaimisi Eliford,Janabi Mohamed,Minzi Omary,Bakari Muhammad,Riedel Klaus-Dieter,Burhenne Juergen,Lindquist Lars,Mugusi Ferdinand,Sandstrom Eric,Aklillu Eleni

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.;A Kwara;Int J Tuberc Lung Dis,2005

2. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.;GL Dean;Aids,2002

3. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.;A Tostmann;J Gastroenterol Hepatol,2008

4. An official ATS statement: hepatotoxicity of antituberculosis therapy.;JJ Saukkonen;Am J Respir Crit Care Med,2006

5. Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal.;DF Wares;Int J Tuberc Lung Dis,2003

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HAART induced inflammation, toxicity and its determinants among HIV positive children in Addis Ababa, Ethiopia;Heliyon;2023-05

2. Effect of pharmacogenetic variations on praziquantel plasma concentration and safety outcomes among school children in Rwanda;Scientific Reports;2023-01-26

3. Safety of Praziquantel and Albendazole Coadministration for the Control and Elimination of Schistosomiasis and Soil-Transmitted Helminths Among Children in Rwanda: An Active Surveillance Study;Drug Safety;2022-07-11

4. CYP3A and CYP2B6 Genotype Predicts Glucose Metabolism Disorder among HIV Patients on Long-Term Efavirenz-Based ART: A Case-Control Study;Journal of Personalized Medicine;2022-06-30

5. Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon;BMC Gastroenterology;2022-06-03